FDA Adverse Event Malfunction Summary report: N

ARCHITECT IPTH

MDR report key: 2983382 · Received February 28, 2013

Report

Report Number
1415939-2013-00078
Event Type
Malfunction
Date Received
February 28, 2013
Date of Event
February 19, 2013
Report Date
February 21, 2013
Manufacturer
ABBOTT LABORATORIES
Product Code
CEW
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PLEASE REFER TO MANUFACTURE REPORT NUMBER 3002809144-2013-00066.

Additional Manufacturer Narrative · 1

AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 08K25-25 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 08K25-27. (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTS FALSELY ELEVATED ARCHITECT INTACT PTH (IPTH) ASSAY RESULTS. ONE PATIENT GENERATED A RESULT OF 78.7 PG/ML. THE SAMPLE WAS THEN TESTED BY AN RIA METHODOLOGY AND GENERATED A RESULT OF 32.7 PG/ML. THE CUSTOMER IS CONCERNED THAT EVEN THOUGH THE ARCHITECT IPTH ASSAY HAS THE SAME REFERENCE RANGE AS THE RIA METHOD THAT THE ARCHITECT RESULTS HAVE SUCH A HIGH BIAS. THE CUSTOMER ALSO EXPRESSED CONCERN THAT EXTERNAL PROFICIENCY TEST RESULTS SHOW THAT THE ARCHITECT IPTH ASSAY IS NOT IN LINE WITH ANY COMPETITOR ASSAY AND DEMONSTRATES A VERY HIGH BIAS. NO SUSPECT RESULTS HAVE BEEN REPORTED FROM THE LAB. THERE IS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
87469 ARCHITECT IPTH CEW ABBOTT LABORATORIES 02112E000

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT I1000SR LN: 01L86-01| SN: (B)(4)| SN: (B)(4)| ARCHITECT I1000SR LN: 01L86-01